-
New and experimental hepatitis C treatment
Bloomberg | 10 hours ago
Gilead Sciences Inc., the drugmaker that acquired Pharmasset Inc.
last month for its experimental hepatitis C treatments, gained the most in three
years after one of the medicines produced positive clinical trial results.
-
Transmission and prevention
Science Speaks: HIV & TB News | 10 hours ago
“This is an extraordinary moment in the AIDS epidemic – we finally have the tools to turn the tide,” said Diane Havlir, MD, of the University of California San Francisco, speaking to the arsenal of HIV prevention interventions the AIDS community now has at its disposal to combat new infections worldwide.
-
Finance and funding
IRIN Plus News | 15 hours ago
With global funding for HIV/AIDS on the decline, Zimbabwe's innovative
AIDS levy - a 3 percent tax on income - has become a promising source of
funding for the country, with a dramatic increase in revenue collected
in the past two years.
-
TB diagnosis
Science Speaks | 15 hours ago
Although recent press attention has highlighted the problematic use of
TB serological tests by medical providers in India, a new paper in The European Respiratory Journal (Widespread use of serological tests for tuberculosis: data from 22 high-burden countries) demonstrates that the use of these tests is much wider spread.
-
Types of tests
Long Island Business News | 15 hours ago
Even as a Pennsylvania-based company made news last month by advancing toward approval for an over-the-counter HIV test, a Long Island company is making strides with its own version of the test.
-
Access to medicines and treatment
Medicines Patent Pool | 16 hours ago
Emcure Pharmaceuticals, a key supplier of generic antiretroviral medicines in
developing countries, has signed an agreement with the Medicines Patent Pool for
the manufacture of several new HIV medicines for sale in developing countries,
it was announced today.
-
Microbicides
All Africa | 16 hours ago
Africans tracking the worldwide HIV epidemic have not found much to
celebrate since Aids began ravaging the continent 30 years ago, but
researchers are optimistic that they are learning as much from their
failures as their successes.
-
Global health initiatives
The Guardian | 16 hours ago
Around 500 activists and people who are HIV-positive
marched through the streets of Nairobi on the 10th anniversary of the launch of
the Global
Fund to Fight Aids, Tuberculosis and Malaria, demanding that western donors
fulfil their promise to finance the organisation.
-
Pharmaceutical industry
CBS News | 02 February 2012
Gilead Sciences Inc.'s profit grew 6 percent in the fourth quarter on greater sales of its HIV drugs including Atripla. Gilead said Thursday that its profit rose to $665.1 million, or 87 cents per share, from $629.4 million, or 76 cents per share.
-
Men who have sex with men (MSM)
Equal Rights Trust | 02 February 2012
On 20 January 2012, a jury in Britain’s Derby Crown Court
delivered a guilty verdict to three out of five men charged with the
offence of stirring up hatred on the grounds of sexual orientation.
Talking points: a checklist for you and your doctorTalking points is designed to help you talk to your doctor about HIV
treatment.
Preventing HIVAn essential resource providing evidence-based information on preventing HIV infection. 
A visit from Wandsworth Oasis26 January 2012On Wednesday this
week, we were delighted to have a visit...
Adventurers with HIV – a photo gallery19 January 2012Back in
November we sent out a
call for adventurous people with...
We’d like to introduce a friend of ours…12 January 2012...